Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban Granules

Approval Number

国药准字H20254065

Company南京海纳制药有限公司

Registration Date

May 13, 2025

Drug Information

Generic Name

利伐沙班颗粒

Dosage Form

颗粒剂

Strength

15mg

Drug Type

化学药品

Registration Date

May 13, 2025

Company Information

Applicant Company

Company Name南京海纳制药有限公司

Company Address

南京市江北新区科创大道18号

Manufacturing Company

Company Name南京海纳制药有限公司

Company Address

南京市江北新区科创大道18号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy